Connect with us

Health & Fitness

AstraZeneca says vaccine 80% effective for elderly, no blood clot risk

AstraZeneca’s Covid-19 vaccine is 80 percent effective at preventing the disease in the elderly and does not increase the risk of blood clots, the biotech firm said Monday, following its US phase III efficiency trials.

Published

on

AstraZeneca says vaccine 80% effective for elderly, no blood clot risk